These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30842734)

  • 1. Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions.
    Derszniak K; Przyborowski K; Matyjaszczyk K; Moorlag M; de Laat B; Nowakowska M; Chlopicki S
    Front Pharmacol; 2019; 10():68. PubMed ID: 30842734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
    Müller J; Freitag D; Mayer G; Pötzsch B
    J Thromb Haemost; 2008 Dec; 6(12):2105-12. PubMed ID: 18826387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the selectivity of thrombin-binding aptamers for thrombin titration in murine plasma.
    Trapaidze A; Hérault JP; Herbert JM; Bancaud A; Gué AM
    Biosens Bioelectron; 2016 Apr; 78():58-66. PubMed ID: 26594887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions.
    Pozzi N; Acquasaliente L; Frasson R; Cristiani A; Moro S; Banzato A; Pengo V; Scaglione GL; Arcovito A; De Cristofaro R; De Filippis V
    J Thromb Haemost; 2013 Jun; 11(6):1093-102. PubMed ID: 23578283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long range communication between exosites 1 and 2 modulates thrombin function.
    Petrera NS; Stafford AR; Leslie BA; Kretz CA; Fredenburgh JC; Weitz JI
    J Biol Chem; 2009 Sep; 284(38):25620-9. PubMed ID: 19589779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix.
    Mendelboum Raviv S; Horváth A; Aradi J; Bagoly Z; Fazakas F; Batta Z; Muszbek L; Hársfalvi J
    J Thromb Haemost; 2008 Oct; 6(10):1764-71. PubMed ID: 18665927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high-anticoagulant thrombin-binding bivalent DNA aptamer-linked M08 with HD22.
    Yoshitomi T; Wakui K; Miyakawa M; Yoshimoto K
    Res Pract Thromb Haemost; 2021 Jun; 5(5):e12503. PubMed ID: 34136744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Through-bond effects in the ternary complexes of thrombin sandwiched by two DNA aptamers.
    Pica A; Russo Krauss I; Parente V; Tateishi-Karimata H; Nagatoishi S; Tsumoto K; Sugimoto N; Sica F
    Nucleic Acids Res; 2017 Jan; 45(1):461-469. PubMed ID: 27899589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
    Hughes QW; Le BT; Gilmore G; Baker RI; Veedu RN
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29048375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
    Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
    Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(methyl methacrylate) microchip affinity capillary gel electrophoresis of aptamer-protein complexes for the analysis of thrombin in plasma.
    Obubuafo A; Balamurugan S; Shadpour H; Spivak D; McCarley RL; Soper SA
    Electrophoresis; 2008 Aug; 29(16):3436-45. PubMed ID: 18702051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
    Goel MS; Diamond SL
    J Biol Chem; 2003 Mar; 278(11):9458-63. PubMed ID: 12524437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets.
    Wu CC; Wang WY; Wei CK; Teng CM
    Thromb Haemost; 2011 Jan; 105(1):88-95. PubMed ID: 21057701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cartilage oligomeric matrix protein is a natural inhibitor of thrombin.
    Liang Y; Fu Y; Qi R; Wang M; Yang N; He L; Yu F; Zhang J; Yun CH; Wang X; Liu J; Kong W
    Blood; 2015 Aug; 126(7):905-14. PubMed ID: 26045608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation impacts thrombin generation assessed by calibrated automated thrombography.
    Didelot M; Docq C; Wahl D; Lacolley P; Regnault V; Lagrange J
    Platelets; 2018 Mar; 29(2):156-161. PubMed ID: 29022492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.
    Iwase H; Ekser B; Zhou H; Dons EM; Cooper DK; Ezzelarab MB
    Xenotransplantation; 2012; 19(4):233-43. PubMed ID: 22909136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional analysis of the simultaneous binding of two duplex/quadruplex aptamers to human α-thrombin.
    Troisi R; Balasco N; Santamaria A; Vitagliano L; Sica F
    Int J Biol Macromol; 2021 Jun; 181():858-867. PubMed ID: 33864869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
    J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.